LOGIN
Landmark vs TCL-Penetrating Corticosteroid Injection for Bilateral Carpal Tunnel Syndrome
July 2025
Landmark vs TCL-Penetrating Corticosteroid Injection for Bilateral Carpal Tunnel Syndrome
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Comparison of Landmark-Based Versus Transverse Carpal Ligament Penetrating Corticosteroid Injection for Bilateral Carpal Tunnel Syndrome: A Prospective Randomized Trial.
Clin Orthop Surg . 2025 Jun;17(3):497-505.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Thirty patients with bilateral carpal tunnel syndrome were randomized to receive a landmark-based corticosteroid injection on one hand and a TCL-penetrating injection on the other. The primary outcome was the symptom domain score of the Boston Carpal Tunnel Questionnaire (BCTQ-S) at 3 months. Secondary outcomes included pain VAS scores, function domain of BCTQ (BCTQ-F), pain during needle insertio...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.